Novel LDTs Advance Dermatological Diagnostics
Molecular Instruments has introduced novel LDTs to improve the diagnosis and treatment of psoriasis and atopic dermatitis.
Molecular Instruments has introduced novel LDTs to improve the diagnosis and treatment of psoriasis and atopic dermatitis.
Higher PVSA compliance rates lead to better clinical outcomes, enhancing the laboratory's reputation and value to healthcare providers.
Researchers have developed a way to detect inflammation through antibodies, potentially enabling blood tests for disease-specific biomarkers.
Verichem Labs introduced an extensive line of liquid-stable, multi-analyte calibration verification kits designed for electrolyte assays.
A study demonstrates safely reducing unnecessary pre-op tests can minimize waste and improve efficiency without compromising patient outcomes.